Natural Killer (NK) Cell Therapeutics Market Size & Outlook, 2023-2031

Natural Killer (NK) Cell Therapeutics Market Size, Share & Trends Analysis Report By Natural Killer (NK) cell Therapy Type (NK Cell Therapy (unmodified), CAR-NK Cell Therapy (modified), NK Cell Engager), By Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), By Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), By Indication (Hepatocellular Carcinoma (HCC), Acute Myeloid Leukemia (AML), Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL), Peripheral T-Cell Lymphoma (PTCL).), By Pipeline Product (AFM13, MG4101, GTA002 (oNKordA), TAK-007) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH54334DR

Last Updated : May, 2023

Pages : 110

Author : Mitiksha Koul

Format : PDF, Excel

Gain an overview of the report's scope and coverage.
Access quantitative and qualitative data that forms part of the final report.
Understand how market segmentations and regional data are presented for both the current and forecast periods.
Explore a comprehensive market definition and the methodology used for market size evaluation.
Discover market share insights about top companies, their industry performance, and strategies.

The sample is available in two formats

Note: Please ensure you provide an active email address as we will be sending sample details via email.

I have read the Terms & Conditions and Privacy Policy, I agree to its terms

The button will be active once the above form is filled